News From The States / Verite: Daniel Cressy begins Casgevy stem-cell collection | Source Library

ArticleGeneral published source

Source type: Article
Access type: Publisher
Publisher: News From The States / Verite News
Date: 2025-08-03
Added: 2026-07-28

Trust profile

VV Source Trust Matrix v1.0

VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.

General published source

Publisher type: General media
Bias profile: Elevated

This source is strongest for consumer context and regulatory status and weaker for safety and trial discovery.

VV Source Fit Score 1.0

Fit by use case

Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.

Frameworks ->

Regulatory status: 54/100; Weak Support
Clinical outcomes: 54/100; Weak Support
Mechanism: 54/100; Weak Support
Safety: 54/100; Weak Support
Consumer context: 67/100; Context Source
Trial discovery: 54/100; Weak Support

Best used for

Context
Public narrative

Weak for

Clinical claims
Safety conclusions
Regulatory status

Used in Viral Vitalism

Backgroundbrief1 reference

A 23-Year-Old in Louisiana Was Functionally Cured of Sickle Cell Disease

Roles: Background

Show section-level references

Timeline correction recorded July 28, 2026Contemporaneous timeline verification for the July 30, 2025 stem-cell collection.

Related studies

No structured study record is currently attached to this source.

Topic tags

sickle-cell-diseasecasgevycrisprgene-therapystem-cell-collectiondaniel-cressypatient-story